Last month in Geneva, Bill Gates laid out his vision for the impact that broadening access to vaccines can have on the world.
Now, only a few weeks after his inspirational speech, GlaxoSmithKline (GSK) has promised to cut a whopping 95% off its rotavirus vaccine for sale to the globe’s poorest countries, while Merck has also said it would cut the price on its vaccine against the same illness, which causes diarrhoea.
Sanofi Pasteur and Johnson & Johnson also promised cuts.
(READ the story in Medical News Today)